Home › NDC Lookup › RxCUI directory › RxCUI 105590

Thioguanine 40 MG Oral Tablet [Tabloid] — RxCUI 105590

RxNorm drug concept · Semantic branded drug
RxCUI 105590 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI105590
Official nameThioguanine 40 MG Oral Tablet [Tabloid]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTabloid 40 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Thioguanine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats acute nonlymphocytic leukemias, helping bring on and consolidate remission. It is usually used together with other chemotherapy drugs. It is not meant for long-term maint...
  • Tabloid tablets are taken by mouth, and the daily dose can be taken all at once. Your oncology team sets the dose and schedule for you. Follow their directions and the label exactl...
  • Low blood counts are the most common effect. You may also have nausea, vomiting, poor appetite, or mouth sores. Your team will check blood counts often.
  • Call right away for fever or signs of infection, unusual bleeding, yellow skin or eyes, belly swelling or tenderness, or fast weight gain. These can signal low blood counts or live...
📖 Read our full Thioguanine guide →

🕸️ Concept Web — How Thioguanine 40 MG Oral Tablet [Tabloid] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Thioguanine 40 MG Oral Tablet [Tabloid] RxCUI 105590

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Thioguanine 10485
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tabloid 151956
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Thioguanine Oral Tablet 374104
    • Thioguanine Oral Product 1165526
    • Thioguanine Pill 1165527
    • Thioguanine Oral Tablet [Tabloid] 368664
    • Tabloid Oral Product 1177820
    • Tabloid Pill 1177821
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Thioguanine 40 MG Oral Tablet SCD · 198269
  • Thioguanine 40 MG SCDC · 316813
  • Thioguanine Oral Tablet SCDF · 374104
  • Thioguanine Oral Product SCDG · 1165526
  • Thioguanine Pill SCDG · 1165527

Brand-Name Concepts

  • Thioguanine 40 MG [Tabloid] SBDC · 564106
  • Thioguanine Oral Tablet [Tabloid] SBDF · 368664
  • Tabloid Oral Product SBDG · 1177820
  • Tabloid Pill SBDG · 1177821
  • Tabloid BN · 151956

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 105590 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
80725-0630-25 1 BOTTLE in 1 CARTON (80725-630-25) / 25 TABLET in 1 BOTTLE TABLOID Waylis Therapeutics LLC 2023-05-15
Observed labelers: Waylis Therapeutics LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.